FindTrial
Sign In

CLINICAL EVALUATION OF KABA SURA KUDINEER IN THE TREATMENT OF KABASURAM (ACUTE BRONCHITIS) IN CHILDREN

Clinical evaluation of kaba sura kudineer in the treatment of kabasuram(Acute bronchitis) in children

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/08/036067
Enrollment
30
Registered
2021-08-31
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J398- Other specified diseases of upperrespiratory tract

Interventions

Intervention1: Kaba sura kudineer: Kaba sura kudineer is given twice a day after food for 3 days. 4-7 years - 15 ml(3gm decoction powder) 7-12 years - 30ml (5 gm decoction powder) Control Intervention

Sponsors

National Institute of Siddha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children with any of the symptoms such as Low grade fever((98.7 <= 100.4 o F) ), difficulty in breathing, dry or productive Cough, running nose ,constipation, polyarthralgia, vomiting , malaise

Exclusion criteria

Exclusion criteria: Temperature > 100.4° F H/o Active primary complex Malaria Typhoid Rheumatic Fever, Urinary tract infection children below 4 years and above 12 years

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of KABA SURA KUDINEER in the treatment of KABASURAM (acute bronchitis) in children Timepoint: 3 DAYS—

Secondary

MeasureTime frame
To ensure the prognosis of Kabasuram by clinical symptoms It is mainly assessed by comparing the reduction in clinical symptoms before and after treatmentTimepoint: after 3 days—

Countries

India

Contacts

Public ContactDr R S Lakshmi Prasannaa

National Institute of Siddha

dramalaaruldhas@gmail.com9940429202

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026